A key regulator of cancer-associated fibroblasts, TWIST1, presented a noticeable focal gain >20%, and a regulator of angiogenesis, VEGFB (vascular endothelial growth factor B), presented a noticeable focal gain >40% (Figure 1F). This evidence concerns the gene VEGFB and cancer.